Publication | Closed Access

A randomized, double-blind, placebo-controlled, Phase II study with and without enzastaurin in combination with docetaxel-based chemotherapy in patients with castration-resistant metastatic prostate cancer

UrologyMedicineDocetaxel-based ChemotherapyPharmacologyClinical TrialsPhase Ii StudyPharmacotherapyCancer TreatmentProstatic DiseaseOncology